Moreover, HIF1α levels increased in tendinopathy in vivo and in tenocytes in vitro, while HIF1 inhibition alleviated the severity of tendinopathy by blocking NFκB and MAPK signaling pathways [150]. Here, HIF1A is linked to disease of the tendon.